L26/P-795 Title: An increase in the dose of exogenous FSH beyond 300 IU in a second cycle improves ovarian stimulation response in normo- or hypo-responding women
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.1122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M. Grynberg und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does increasing the FSH dose beyond 300IU/day in a second ovarian stimulation cycle improve the number of metaphase II oocytes of in normo- and hypo-responders? Summary answer After a poor response to a first high-dose stimulation, increasing FSH administration beyond 300 IU/day improves ovarian response, number of recovered and metaphase II oocytes. What is known already In the absence of a qualitative oocyte marker, the main objective of ovarian stimulation in normo- and hypo-responders—both for infertility treatment or fertility preservation—often remains to maximize the number of mature oocytes retrieved, which has been related to the success rate. While 300 IU/day of FSH is commonly considered the maximum effective dose, some normo- and hypo-responding women might benefit from dose escalation. However, data from intra-patient comparisons remain scarce. This investigation aimed to evaluate whether increasing the FSH dose beyond 300 IU/day in a second ovarian stimulation cycle improves the number of metaphase II oocytes in normo- and hypo-responders. Study design, size, duration Retrospective, bicentric, intra-patient study between January 2020 and July 2024. Participants/materials, setting, methods The present study included women having undergone two ovarian stimulation cycles (within 12 months), using antagonist or progestin-primed ovarian stimulation protocols for IVF or fertility preservation. Only cycles with starting FSH doses ≥ 300 IU/day were considered. Patients were grouped according to whether their second cycle used a similar or increased gonadotropin dose. Main outcomes were the number of retrieved and mature (MII) oocytes. Main results and the role of chance Among 818 patients, 305 underwent a dose increase in the second cycle. Both groups showed a statistically significant increase in oocyte and MII counts between cycles. However, the increase was significantly greater in the increased-dose group (mean oocyte gain: +1.55 vs. +0.47; p < 0.0001). A higher proportion of patients in the increased-dose group achieved improved oocyte retrieval outcomes. We failed to observe and impact of the pretreatment used (17-b estradiol vs. oral contraceptive pill) nor of the utilization of LH activity preparations. Limitations, reasons for caution In addition to its retrospective nature, the main limitations include a relatively small sample size due to strict inclusion criteria, the type of trigger (double or not) which might also have impacted the number of MII oocytes. Moreover, we did not analyze the outcomes after oocyte utilization. Wider implications of the findings We demonstrated that, in normo- and hypo-responders, increasing the dose of gonadotropins may improve the number mature oocytes retrieved—a key factors for IVF and fertility preservation success. These findings, independent of pretreatment regimen and LH supplementation, warrant confirmation through prospective studies that also include outcome data on the retrieved oocytes. Trial registration number No
Zitieren
APA
Grynberg, M., Sanbar, P., Sellami, I., Bedin, A., Thomas, H., & Sonigo, C. (2026). L26/P-795 Title: An increase in the dose of exogenous FSH beyond 300 IU in a second cycle improves ovarian stimulation response in normo- or hypo-responding women. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1122
Vancouver
Grynberg M, Sanbar P, Sellami I, Bedin A, Thomas H, Sonigo C. L26/P-795 Title: An increase in the dose of exogenous FSH beyond 300 IU in a second cycle improves ovarian stimulation response in normo- or hypo-responding women. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1122
BibTeX
@article{Grynberg2026,
author = {Grynberg, M. and Sanbar, P. and Sellami, I. and Bedin, A. and Thomas, H. and Sonigo, C.},
title = {L26/P-795 Title: An increase in the dose of exogenous FSH beyond 300 IU in a second cycle improves ovarian stimulation response in normo- or hypo-responding women},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.1122}
}
EUVIMED